Competition authorities in the UK have recommended that resale price maintenance

(where manufacturers dictate retail prices) for over the counter non-prescription drugs should be abolished. If retailers are free to set their own prices it is assumed that the supermarkets will grow their share of the market at the expense of independent pharmacists. Should this happen, what impact might it have on the drug manufacturers themselves? The public will benefit in terms of prices, but is the situation more complex?